CP
AURA icon

Caligan Partners’s Aura Biosciences AURA Stock Holding History

Caligan Partners’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.54M Buy
+229,864
New +$1.32M 0.1% 27
2025
Q4 		– Sell
-227,174
Closed -$1.4M – 27
2025
Q3 		$1.4M Buy
227,174
+27,174
+14% +$178K 0.18% 18
2025
Q2 		$1.25M Buy
+200,000
New +$1.17M 0.24% 17

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Caligan Partners's AURA Position: Q1 2026 in Review

Caligan Partners opened a new position in Aura Biosciences (AURA) in Q1 2026: 229,864 shares worth $1.54M. The stake represents 0.1% of the portfolio and ranks #27 among its holdings. This is a return to the name: Caligan Partners previously reported a position in AURA as recently as Q3 2025.

Caligan Partners first reported a position in AURA in Q2 2025 and has held it in 3 quarters since. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Caligan Partners held 229,864 shares of Aura Biosciences worth $1.54M as of Q1 2026.
  • Aura Biosciences was a new Caligan Partners position in Q1 2026.
  • Aura Biosciences made up 0.1% of Caligan Partners's portfolio in Q1 2026, its #27 holding.
  • Caligan Partners first reported a position in Aura Biosciences in Q2 2025 and has held it in 3 quarters since.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Caligan Partners's 13F filing for Q1 2026, filed 15 May 2026.